FDA Pushes Back Action Date For Nuvigil Label Expansion Due To New Data
This article was originally published in The Pink Sheet Daily
Executive Summary
Cephalon, which has positioned Nuvigil to replace Provigil as the latter sleep drugs faces patent expiry, hopes to add treatment of jet lag to label.
You may also be interested in...
Cephalon's Nuvigil Jet Lag Indication Grounded By Complete Response Letter
Wall Street analysts question the extent to which the FDA move is a setback, given the outlook for the company's wakefulness franchise.
Cephalon's Nuvigil Jet Lag Indication Grounded By Complete Response Letter
Wall Street analysts question the extent to which the FDA move is a setback, given the outlook for the company's wakefulness franchise.
An Easy Landing? Cephalon Scores Priority Review For Nuvigil In Jet Lag Disorder
Some, however, remain skeptical of the medicine's potential after the Provigil patent expires.